QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Cardiac Surgery
In brief
This trial is designed to evaluate QPI-1002 versus placebo for the prevention of Major Adverse Kidney Events (MAKE) in subjects at high risk for acute kidney injury following cardiac surgery. Half of the participants will receive QPI-1002 while the other half will receive placebo.
Key facts
- Study ID
- NCT03510897
- Run by
- Quark Pharmaceuticals
- People needed
- 1043
- Starts
- 2018-06-29
- Expected to finish
- 2021-04-12
- Last updated by the study team
- 2021-07-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Keck Hospital of USC — Los Angeles, California, United States
- Cedar-Sinai Heart Institute — Los Angeles, California, United States
- Ronald Regan UCLA Medical Center — Los Angeles, California, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- River City Clinical Research — Jacksonville, Florida, United States
- Jacksonville Center for Clinical Research — Jacksonville, Florida, United States
- Emory Saint Joseph's Hospital — Atlanta, Georgia, United States
- Northwestern University — Evanston, Illinois, United States
- Indiana/ Ohio Heart, a division of Luthern Medical Group, LLC — Fort Wayne, Indiana, United States
- Indiana University Health-Methodist Hospital — Indianapolis, Indiana, United States
- University of Kentucky Healthcare — Lexington, Kentucky, United States
- University of Louisville Physicians (ULP) — Louisville, Kentucky, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- MidMichigan Medical Center Midland — Midland, Michigan, United States
- Cardiac & Vascular Research Center of Northern Michigan — Petoskey, Michigan, United States
- Saint Luke's Hospital of Kansas City — Kansas City, Missouri, United States
- Bryan Heart — Lincoln, Nebraska, United States
- Nebraska Heart Hospital — Lincoln, Nebraska, United States
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
- Saint Barnabas Medical Center — Livingston, New Jersey, United States
- Columbia University Medical Center — New York, New York, United States
- Mission Hospital, Inc. — Asheville, North Carolina, United States
- Duke University Hospital Medical Center — Durham, North Carolina, United States
- East Carolina Heart Institute at East Carolina University — Greenville, North Carolina, United States
- University of Alabama at Birmingham Hospital — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.